242 results
Page 3 of 13
6-K
EX-99
578 xke0m
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
d5hczllkk0h
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
ba773ls70f3hqlebz
4 May 21
BioLineRx Announces Positive Top-Line Results from
7:12am
6-K
EX-99
ml6ok8 zq3
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
ap7n2y
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
96c2p92y g02fld5df
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
13pxfli0o 10g08a
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
tx7u tmiryq
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
s7dbs
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-99
ak9ozhfehw
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
EX-99
owijr04y8sn1e eq5i
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
EX-99
alkkh3 6vm85z6cbg
18 Nov 20
BioLineRx Announces Initiation of Phase 1b Clinical Trial
7:09am
424B5
6xvqic02
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-1
osqgton6i
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-99
bnh01 nkvqxvx4
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
EX-10.1
zwehu5s
25 Sep 20
Current report (foreign)
4:33pm
424B5
dphes5c56u2z
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
96clko1zxu
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
6-K
EX-99
ihh2zp2b7 pou
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am